Prime Focus Limited moves to reshape its capital structure

The resolution does not select one instrument. It is an enabling approval for a raise of up to Rs 3,000 Crores through equity shares and/or debt or non-convertible securities, share warrants, and other equity-linked securities, using mechanisms such as QIP, preferential issue, rights issue, ADR/GDR or other permitted modes. The final instrument, pricing, mix and number of tranches remain for the Board to determine, subject to shareholder and regulatory approvals. ^[1]

Authorized capital and potential dilution

The proposed authorized share capital rises from Rs 85 Crores, comprising 85 Crore equity shares of Re 1 each, to Rs 100 Crores, comprising 100 Crore equity shares of Re 1 each. This creates 15 Crore additional authorized equity shares. ^[2]

The latest reported paid-up equity share capital is Rs 77.65 Crores, with a Re 1 face value. ^{[3] [4]} On that basis:

• Current paid-up base: approximately 77.65 Crore shares.
• Incremental authorized capacity: 15 Crore shares, equivalent to 19.32% of the current paid-up base.
• If all 15 Crore additional shares were issued, existing shareholders’ ownership would reduce to approximately 83.81%, implying dilution of about 16.19% on a post-issue basis.
• Total authorized headroom after the proposed increase would be 22.35 Crore shares—100 Crore authorized less 77.65 Crore currently paid up. If the entire headroom were ultimately issued, the mechanical dilution would be approximately 22.35% of the post-issue equity base.

These percentages are equity-share scenarios only. The Rs 3,000 Crore fundraising limit cannot be translated into a definitive share count because the resolution does not disclose the issue price or confirm that the raise will be entirely equity-funded. For illustration, using only the 15 Crore incremental shares, a fully equity-funded Rs 3,000 Crore raise would imply an average issue price of Rs 200 per share; using the entire 22.35 Crore post-increase headroom would imply approximately Rs 134.23 per share. These are mechanical thresholds, not disclosed terms.

Implication: the authorized-capital increase provides some equity issuance capacity, but it does not establish the eventual dilution. Debt or non-convertible securities could fund part or all of the raise without immediate equity dilution, while warrants or other equity-linked instruments could create dilution later upon conversion or exercise.

The board resolution does not specify a ring-fenced end-use for the Rs 3,000 Crore. It authorises raising up to Rs 3,000 Crore through equity, debt, convertibles, QIP, preferential issue, rights issue or other permitted instruments; the specific structure and tranches are to be decided later, subject to shareholder and regulatory approvals ^[5]. The annexure likewise describes the securities and issuance routes, but does not earmark the proceeds for debt repayment, capex, acquisitions or any other stated purpose ^[1].

Alignment with the FY26 financial position

• Net debt: Consolidated net debt was Rs 4,252.4 Crores in FY26, with net debt/EBITDA of 2.78x ^{[6] [7]}. The proposed maximum raise is therefore equivalent to approximately 70.55% of FY26 net debt—a material amount if deployed toward deleveraging. This is a derived comparison from the two reported figures.
• Capex base: FY26 consolidated capex-to-revenue was 11.4%, while capital work in progress stood at Rs 66.04 Crores ^{[8] [9]}. These figures indicate ongoing investment, but they do not disclose a forward capex budget or project-wise funding requirement.
• Interpretation: The raise is financially consistent with two possible needs—reducing a sizeable consolidated debt burden or funding continued expansion—but the resolution does not tell investors which one is intended. If raised as equity and used for debt reduction, it could materially lower leverage; if raised as debt, it would not address the existing leverage burden. If directed to capex, the disclosed annual-report metrics are insufficient to determine whether Rs 3,000 Crores is proportionate to the actual project pipeline.

Bottom line: The stated end-use is not specified. The size of the proposed raise is large relative to net debt, while disclosed capex indicators show investment activity but no quantified future requirement. Accordingly, the capital-allocation rationale remains dependent on the eventual instrument, use-of-proceeds disclosure and project-level capex details.

The Rs 3,000 crore fundraise is very large relative to Prime Focus’s current consolidated net worth: it equals approximately 144% of FY26 consolidated equity, or 1.44 times net worth. On the latest reported balance-sheet base, the raise would exceed net worth by about Rs 912 Crores, derived from Rs 3,000 Crores less Rs 2,088.5 Crores of consolidated equity ^[10].

Balance-sheet implication: this is not a marginal equity top-up. Relative to FY26, the proposed amount is larger than the entire existing equity base and equivalent to roughly 61% of gross debt. It is also about 4.36 times FY26 consolidated cash and equivalents of Rs 688.29 Crores, derived from Rs 3,000 Crores divided by Rs 688.29 Crores ^[13]. The economic effect will depend on the use of proceeds, issue pricing, dilution and whether the funds refinance debt, finance acquisitions or support expansion.

Historical precedent: the reported financial record does not establish a clear precedent for a prior capital raise of this scale. The consolidated equity-share-capital line increased from Rs 30.00 Crores in FY25 to Rs 77.60 Crores in FY26, an increase of Rs 47.60 Crores, derived from the reported figures ^[14]. That is only about 1.59% of the proposed Rs 3,000 crore raise. However, share capital is not the same as total funds raised: any securities premium, other equity, acquisition-related consolidation or non-cash accounting movements would need to be separately identified before treating that change as a historical fundraise.

Conclusion: relative to Prime Focus’s current balance sheet, Rs 3,000 Crores would be an unusually large transaction—about 1.44 times current consolidated net worth and 3.95 times FY25 net worth. The available historical financial lines show balance-sheet growth, but they do not document a prior equity raise of comparable magnitude relative to the company’s equity base.